Study design
CMO
After ethical approval (Ethics Committee CMO Arnhem-Nijmegen, Number 2019-5488), this single-blinded intervention study was performed in an outpatient clinic in a tertiary care hospital in Nijmegen, the Netherlands. The study was registered in the Dutch Trial Register (NL8221). Data was collected between January 2020 and October 2020.